| breast cancer - triple negative | |||||
| mBC - Triple negative (TNBC) - (neo)adjuvant (NA) | la/mBC - TNBC - L1 - all population | la/mBC - TNBC - L1 - PDL1 positive | la/mBC - TNBC - L2 - all population | la/mBC - TNBC - L2 - PDL1 positive | |
| atezolizumab based treatment | NSABP B-59/GBG 96-GeparDouze NSABP B-59/GBG 96-GeparDouze | IMpassion-132 ... TBCRC Alice IMpassion-132 ... | IMpassion-132 ... IMpassion-132 ... | ||
| atezolizumab plus nab-paclitaxel | IMpassion-130 ... | IMpassion-130 ... | |||
| atezolizumab plus paclitaxel | IMpassion-131 ... | IMpassion-131 ... | |||
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
